Cell-Free DNA Versus Circulating Tumor Cells: A Pilot Study of Alpha-Fetoprotein Analysis for Diagnosis and Treatment Monitoring in Hepatocellular Carcinoma
Biosensors · 04.09.2025 · 15 (9) · 579
DOI: 10.3390/bios15090579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 04.09.2025. Verfasst von Ga Young Moon und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, alpha-Fetoproteins, Liver Neoplasms, Neoplastic Cells, Circulating. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Fund for Regenerative Medicine, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Serum alpha-fetoprotein (AFP) is widely used for hepatocellular carcinoma (HCC) management, yet its limited sensitivity and specificity restrict diagnostic and prognostic utility. In this study, we explore the clinical potential of AFP quantification from cell-free DNA (cfDNA) and circulating tumor cells (CTCs) using a novel bead-based liquid biopsy platform. Following isolation, AFP abundance in cfDNA was quantified by qPCR, while AFP protein expression in CTCs was assessed via immunohistochemistry. Compared to serum AFP, cfDNA-derived AFP demonstrated significantly greater diagnostic accuracy in distinguishing HCC patients from non-cancerous individuals (p < 0.0001, AUC = 0.998), while AFP+ CTCs showed high specificity. Post-treatment changes in AFP levels from cfDNA and CTCs were significantly associated with therapeutic response and overall survival, outperforming conventional serum AFP. Longitudinal monitoring further revealed that cfDNA AFP levels reliably captured recurrence events prior to clinical diagnosis. Moreover, a combined metric integrating AFP levels from cfDNA and CTCs significantly improved response stratification (AUC = 0.89), outperforming individual biomarkers. This pilot study highlights the potential of multimodal AFP profiling through cfDNA and CTCs as a promising, non-invasive approach for enhancing diagnosis, prognosis, and treatment monitoring in HCC, with direct implications for personalized therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences and Bioengineering, Inha University, 100 Inha-ro, Michuhol-gu, Incheon 22212, Republic of Korea.
- Department of Medical Science, Chungnam National University, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea.
- Department of Internal Medicine, College of Medicine, Chungnam National University, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea.
- Department of Internal Medicine, Chungnam National University Hospital, 282 Munwha-ro, Jung-gu, Daejeon 35015, Republic of Korea.
- Department of Biomedical Laboratory Science, Daegu Health College, Chang-Ui Building, 15 Yeongsong-ro, Buk-gu, Daegu 41453, Republic of Korea.
- Biomedical Research Institute, Inha University Hospital, 27 Inhang-ro, Jung-gu, Incheon 22332, Republic of Korea.
ORCID-Profile: Hyuk Soo Eun, Tae Hee Lee
Förderung
- National Research Foundation of Korea
- Korean Fund for Regenerative Medicine
- Korea Health Industry Development Institute
- Korea Technology & Information Promotion Agency for SMEs
- National Research Council of Science and Technology
- National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT
- Korea Technology & Information Promotion Agency for SMEs
- National Research Council of Science and Technolog
Zitieren
APA
Moon, G. Y., Park, H. S., Kim, H. N., Choi, H. G., Han, Y., Eun, H. S., Lee, T. H., & Bu, J. (2025). Cell-Free DNA Versus Circulating Tumor Cells: A Pilot Study of Alpha-Fetoprotein Analysis for Diagnosis and Treatment Monitoring in Hepatocellular Carcinoma. Biosensors, 15(9), 579. https://doi.org/10.3390/bios15090579
Vancouver
Moon GY, Park HS, Kim HN, Choi HG, Han Y, Eun HS, et al. Cell-Free DNA Versus Circulating Tumor Cells: A Pilot Study of Alpha-Fetoprotein Analysis for Diagnosis and Treatment Monitoring in Hepatocellular Carcinoma. Biosensors. 2025;15(9):579. doi:10.3390/bios15090579
BibTeX
@article{Moon2025,
author = {Moon, Ga Young and Park, Hyun Sung and Kim, Ha Neul and Choi, Hei-Gwon and Han, Yonghan and Eun, Hyuk Soo and Lee, Tae Hee and Bu, Jiyoon},
title = {Cell-Free DNA Versus Circulating Tumor Cells: A Pilot Study of Alpha-Fetoprotein Analysis for Diagnosis and Treatment Monitoring in Hepatocellular Carcinoma},
journal = {Biosensors},
year = {2025},
volume = {15},
number = {9},
pages = {579},
doi = {10.3390/bios15090579}
}
EUVIMED